Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Cited In for PubMed (Select 9539131)

1.

The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis.

Cooper-Knock J, Kirby J, Highley R, Shaw PJ.

Neurotherapeutics. 2015 Apr;12(2):326-39. doi: 10.1007/s13311-015-0342-1.

2.

Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia.

Fiorentino A, Sharp SI, McQuillin A.

Eur J Hum Genet. 2014 Nov 19. doi: 10.1038/ejhg.2014.261. [Epub ahead of print]

PMID:
25406999
3.

Decreased EAAT2 protein expression in the essential tremor cerebellar cortex.

Lee M, Cheng MM, Lin CY, Louis ED, Faust PL, Kuo SH.

Acta Neuropathol Commun. 2014 Nov 13;2:157. doi: 10.1186/s40478-014-0157-z.

4.

Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells.

Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL.

Science. 2014 Sep 5;345(6201):1139-45. doi: 10.1126/science.1254917. Epub 2014 Jul 31.

5.

Ceftriaxone preserves glutamate transporters and prevents intermittent hypoxia-induced vulnerability to brain excitotoxic injury.

Jagadapillai R, Mellen NM, Sachleben LR Jr, Gozal E.

PLoS One. 2014 Jul 11;9(7):e100230. doi: 10.1371/journal.pone.0100230. eCollection 2014.

6.

RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD.

Neuron. 2013 Oct 16;80(2):415-28. doi: 10.1016/j.neuron.2013.10.015. Erratum in: Neuron. 2013 Nov 20;80(4):1102. Heusler, Aaron R [corrected to Haeusler, Aaron R].

7.

Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.

Diaper DC, Adachi Y, Lazarou L, Greenstein M, Simoes FA, Di Domenico A, Solomon DA, Lowe S, Alsubaie R, Cheng D, Buckley S, Humphrey DM, Shaw CE, Hirth F.

Hum Mol Genet. 2013 Oct 1;22(19):3883-93. doi: 10.1093/hmg/ddt243. Epub 2013 May 31.

8.

Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, van den Berg LH, Ringel S.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:5-18. doi: 10.3109/21678421.2013.778548.

9.

Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.

Yoon H, Radulovic M, Wu J, Blaber SI, Blaber M, Fehlings MG, Scarisbrick IA.

J Neurochem. 2013 Oct;127(2):283-98. doi: 10.1111/jnc.12293. Epub 2013 May 27.

10.

Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1.

Morel L, Regan M, Higashimori H, Ng SK, Esau C, Vidensky S, Rothstein J, Yang Y.

J Biol Chem. 2013 Mar 8;288(10):7105-16. doi: 10.1074/jbc.M112.410944. Epub 2013 Jan 30.

11.

Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application.

Benkler C, Offen D, Melamed E, Kupershmidt L, Amit T, Mandel S, Youdim MB, Weinreb O.

EPMA J. 2010 Jun;1(2):343-61. doi: 10.1007/s13167-010-0026-1. Epub 2010 Jun 29.

12.

Alternative polyadenylation: new insights from global analyses.

Shi Y.

RNA. 2012 Dec;18(12):2105-17. doi: 10.1261/rna.035899.112. Epub 2012 Oct 24. Review.

13.

Glutamate signaling in bone.

Brakspear KS, Mason DJ.

Front Endocrinol (Lausanne). 2012 Aug 6;3:97. doi: 10.3389/fendo.2012.00097. eCollection 2012.

14.

Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation.

Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM.

Neuropathology. 2013 Apr;33(2):122-33. doi: 10.1111/j.1440-1789.2012.01332.x. Epub 2012 Jun 18.

15.

Altered astrocyte glutamate transporter regulation of hypothalamic neurosecretory neurons in heart failure rats.

Potapenko ES, Biancardi VC, Zhou Y, Stern JE.

Am J Physiol Regul Integr Comp Physiol. 2012 Aug 1;303(3):R291-300. doi: 10.1152/ajpregu.00056.2012. Epub 2012 Jun 13.

16.

Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders.

Visconte V, Makishima H, Maciejewski JP, Tiu RV.

Leukemia. 2012 Dec;26(12):2447-54. doi: 10.1038/leu.2012.130. Epub 2012 May 15. Review.

17.

The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Redler RL, Dokholyan NV.

Prog Mol Biol Transl Sci. 2012;107:215-62. doi: 10.1016/B978-0-12-385883-2.00002-3. Review.

18.

Misregulated RNA processing in amyotrophic lateral sclerosis.

Polymenidou M, Lagier-Tourenne C, Hutt KR, Bennett CF, Cleveland DW, Yeo GW.

Brain Res. 2012 Jun 26;1462:3-15. doi: 10.1016/j.brainres.2012.02.059. Epub 2012 Mar 3. Review.

19.

Intercellular (mis)communication in neurodegenerative disease.

Garden GA, La Spada AR.

Neuron. 2012 Mar 8;73(5):886-901. doi: 10.1016/j.neuron.2012.02.017. Review.

20.

Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis.

Thompson M, Marecki JC, Marinesco S, Labrie V, Roder JC, Barger SW, Crow JP.

J Neurochem. 2012 Feb;120(4):598-610. doi: 10.1111/j.1471-4159.2011.07601.x. Epub 2012 Jan 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk